Cyclic Quaternary Ammonium Salts for Prolonged Local Anesthesia
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current local anesthetics lack a combination of effective local anesthesia, prolonged duration, rapid onset, good safety, and low skin irritation, particularly for managing postoperative and chronic pain.
Innovation Solution
A novel cyclic quaternary ammonium salt compound with a specific structural formula, allowing for prolonged local anesthesia without motor nerve damage or neurotoxicity, produced through a reaction between specific electron-withdrawing leaving groups.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If QX-314 is combined with local anesthetics or TRP channel agonists to enable membrane traversal, then prolonged local anesthetic effect is achieved, but local neurotoxicity and systemic toxicity increase
Solution Approach 1:
The patent uses TRPV1 channel agonists as intermediaries that temporarily open the TRPV1 channel to allow the quaternary ammonium salt (which cannot pass through the membrane on its own) to traverse the cell membrane. This mediator approach enables membrane traversal without direct interaction between the anesthetic and harmful membrane components, reducing neurotoxicity while achieving prolonged effect
Solution Approach 2:
The patent modifies the chemical structure by using cyclic quaternary ammonium salts with specific ring structures (piperidine, piperazine, morpholine rings) and aromatic substituents, changing the physical and chemical parameters of the molecule to reduce neurotoxicity while maintaining the ability to produce prolonged local anesthetic effect when combined with TRPV1 agonists
2Reliability
If conventional local anesthetics are used to achieve effective local anesthesia, then pain relief is provided, but the duration of action is limited to no longer than 8 hours
Solution Approach 1:
The patent creates a composite therapeutic approach by combining cyclic quaternary ammonium salts (which provide prolonged action when they can enter cells) with TRPV1 channel agonists (which facilitate membrane traversal). This composite system achieves both effective local anesthesia and extended duration beyond what conventional single-agent local anesthetics can provide
Solution Approach 2:
The patent introduces dynamic elements by using TRPV1 channel agonists that temporarily activate the channel, creating a time-dependent window for membrane traversal. This dynamic approach allows the anesthetic to enter cells during the activated period and remain trapped inside, extending the duration of action while maintaining reliability
3Duration of action of moving object
If QX-314 is used alone to block sodium ion currents, then long-lasting anesthetic effect is produced, but the permanent positive charge hinders ability to pass through lipid-soluble cell membrane
Solution Approach 1:
The patent employs TRPV1 channel agonists as mediators that temporarily open the TRPV1 channel, creating a pathway for the charged quaternary ammonium salt to traverse the lipid membrane. The mediator facilitates the otherwise impossible membrane traversal while allowing the anesthetic to reach its intracellular target for prolonged action
Solution Approach 2:
The patent replaces the mechanical/physical process of passive diffusion through the lipid membrane with a channel-mediated transport mechanism. By substituting the direct membrane penetration mechanism with TRPV1 channel-facilitated transport, the patent enables the charged molecule to traverse the membrane effectively
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound provides prolonged local anesthesia with rapid onset and minimal side effects, suitable for various administration routes including transdermal and intravenous applications.
Implementation Method 1
QX-314, a quaternary ammonium salt derivative of lidocaine, can effectively block sodium ion currents after passing through the cell membrane
Implementation Method 2
These local anesthetics act by binding to specific sites on sodium channels in the nerve cell membrane, which reduces the influx of Na+ and alters the membrane potential
Data Source
AI summary
Provided in the present application are a cyclic quaternary ammonium salt compound, and a preparation method therefor and the use thereof. Further provided are the cyclic quaternary ammonium salt compound as represented by general formula (I), or an isomer or a solvate thereof and a composition thereof and the use thereof in the preparation of anesthetic or analgesic drugs. Each substituent in the general formula (I) is the same as that defined in the description.